ArticleScientific reports2016

Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke.

Michael J Van Kanegan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.